Dry Eye Drugs Market

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

Dry Eye Drugs Market contains market size and forecasts of Dry Eye Drugs in global, including the following market information:

• Global Dry Eye Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Dry Eye Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Dry Eye Drugs companies in 2021 (%)

The global Dry Eye Drugs market was valued at 8827.4 million in 2021 and is projected to reach US$ 18890 million by 2028, at a CAGR of 11.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Artificial Tears Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dry Eye Drugs include Allergan, Novartis AG, Bausch Health, Santen Pharma, Takeda, Johnson & Johnson, United Laboratories, Senju Pharmaceutical and Jianfeng Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dry Eye Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dry Eye Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dry Eye Drugs Market Segment Percentages, by Type, 2021 (%)

• Artificial Tears
• Anti-inflammatory Drugs
• Other

Global Dry Eye Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dry Eye Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drug Stores
• Online Pharmacies

Global Dry Eye Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dry Eye Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Dry Eye Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Dry Eye Drugs revenues share in global market, 2021 (%)
• Key companies Dry Eye Drugs sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Dry Eye Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Novartis AG
• Bausch Health
• Santen Pharma
• Takeda
• Johnson & Johnson
• United Laboratories
• Senju Pharmaceutical
• Jianfeng Group
• Eusan GMBH